| Open |
S1905 |
PI/II OBI-3424 for R/R T-ALL/T-LBL |
8/17/2020 |
|
36% |
|
|
| Closed |
S1318 |
PII Blinatumomab/POMP for Elderly Ph-Neg ALL |
1/12/2015 |
9/29/2021 |
98% |
|
|
| Closed |
S1211 |
PII Optimal Induction for HRMM |
10/12/2012 |
|
100% |
|
|
| Closed |
S1203 |
PIII 7+3 vs IA vs IA+vorinostat for AML |
12/15/2012 |
11/4/2015 |
96% |
|
|
| Closed |
S1803 |
PIII Daratumumab + Lenalidomide Post-Auto SCT Maint for MM |
6/27/2019 |
1/15/2025 |
100% |
|
|
| Closed |
SWOG-9051 |
Pilot Evaluation of Combined Hepatic Chemoembolization and Systemic Chemotherapy with 5-FU and Folinic Acid for Metastatic Adenocarcinoma of the Colon and Rectum, Phase II |
4/15/1992 |
4/1/1995 |
100% |
|
Published
|
| Closed |
SWOG-9009 |
Pilot Study for Analysis of Lymphocyte Subsets and Natural Killer Activity after Treatment with Levamisole |
12/15/1990 |
8/7/1992 |
95% |
|
Published
|
| Closed |
SWOG-8572 |
Pilot Study of Continuous Low-Dose 5-Fluorouracil Infusion and Radiation Therapy as Adjuvant Treatment for Duke's-C Colon and Rectal Cancer |
5/9/1986 |
6/15/1991 |
64% |
|
Published
|
| Closed |
SWOG-8750 |
Pilot Study to Examine Cytogenetic Abnormalities in Patients with Acute Leukemia, Ancillary |
4/15/1987 |
10/15/1991 |
|
|
Published
|
| Closed |
SWOG-200 |
Plan for a Cooperative Study in the Evaluation of the Effectiveness of Chemotherapeutic Agents in the Treatment of a Broadspectrum of Malignant Diseases in Adults |
6/23/1961 |
|
6% |
|
|
| Closed |
SWOG-9021 (INT-0124) (BTCG-9021) (RTOG-9021) |
Pos Op RT Single Brain Met |
7/15/1991 |
12/1/1994 |
25% |
|
Published
|
| Closed |
SWOG-9239 |
Post-Organ Transplant Lymphoproliferation Treatment |
4/15/1995 |
8/15/2000 |
40% |
|
Published
|
| Closed |
S2302 |
PRAGMATICA - LUNG |
3/6/2023 |
12/20/2024 |
100% |
|
|
| Closed |
S0000A |
PREADVISE |
5/17/2002 |
9/30/2009 |
72% |
|
Published
|
| Closed |
SWOG-9037 (CALGB-9196) |
Prediction of Recurrence and Survival in Node-Negative Breast Cancer Patients Using a Panel of Prognostic Factors: A Companion Protocol to SWOG-8897 (EST-2188, CALGB-8897, INT-0102) |
9/1/1990 |
5/15/1993 |
100% |
|
|
| Closed |
SWOG-8006 |
Preoperative Reductive Chemotherapy for Stage III or IV Operable Epidermoid Carcinoma of the Oral Cavity, Oropharynx, Hypopharynx or Larynx |
7/14/1980 |
2/20/1985 |
|
|
Published
|
| Closed |
SWOG-9321 |
Previously Untreated MM |
1/15/1994 |
9/15/2000 |
90% |
|
Published
|
| Closed |
SWOG-9119 |
Primary Chemotherapy of Poor Prognosis Soft Tissue Sarcomas, Phase II |
12/15/1991 |
6/15/1998 |
66% |
|
Published
|
| Open |
S2409 |
PRISM: PRecIsion in SCLC via a Multicohort Study: Randomized Phase II studies evaluating maintenance Durvalumab with or without Biomarker-Directed Therapy for Extensive Stage Small Cell Lung Cancer … |
|
|
0% |
|
|
| Open |
S1931 |
PROBE trial |
11/16/2020 |
|
42% |
|
|
